{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:08:20Z","timestamp":1773335300881,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijid.2020.10.021","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T17:11:57Z","timestamp":1602868317000},"page":"53-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["COVID toes: where do we stand with the current evidence?"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-7939","authenticated-orcid":false,"given":"Marie","family":"Baeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7000-1672","authenticated-orcid":false,"given":"Anne","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijid.2020.10.021_bib0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40257-020-00558-4","article-title":"Cutaneous Manifestations of COVID-19: An Evidence-Based Review","volume":"21","author":"Daneshgaran","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0010","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries [published online ahead of print, 2020 Jul 2]","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0015","article-title":"Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals [published online ahead of print, 2020 Jun 3]","author":"Kluger","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ijid.2020.10.021_bib0020","first-page":"e202368","article-title":"Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic [published online ahead of print, 2020 Jun 25]","author":"Herman","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0025","article-title":"Chilblains and COVID-19: further evidence against a causal association [published online ahead of print, 2020 Aug 31]","author":"Baeck","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.ijid.2020.10.021_bib0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2020.05.145","article-title":"Chilblain-like acral lesions during the covid-19 pandemic (\"covid toes\"): histologic, immunofluorescence and immunohistochemical study of 17 cases","volume":"83","author":"Kanitakis","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0035","article-title":"Are chilblains a skin expression of COVID-19 microangiopathy? [published online ahead of print, 2020 Jul 13]","author":"Baeck","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.021_bib0040","first-page":"302","article-title":"Clinical and Coagulation Characteristics of 7 Patients With Critical COVID-2019 Pneumonia and Acro-Ischemia","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"10.1016\/j.ijid.2020.10.021_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.ijid.2020.10.021_bib0050","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases [published online ahead of print, 2020 Jun 20]","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ijid.2020.10.021_bib0055","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19338","article-title":"COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient [published online ahead of print, 2020 Jun 25]","author":"Santonja","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ijid.2020.10.021_bib0060","article-title":"Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned [published online ahead of print, 2020 Aug 15]","author":"Baeck","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0065","doi-asserted-by":"crossref","DOI":"10.1111\/cup.13830","article-title":"Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2 [published online ahead of print, 2020 Aug 3]","author":"Ko","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0070","article-title":"No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain [published online ahead of print, 2020 Jul 1]","author":"Caselli","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16682","article-title":"A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection [published online ahead of print, 2020 May 31]","author":"El Hachem","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0080","article-title":"Major cluster of pediatric \" true \" primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown [published online ahead of print, 2020 Jun 13]","author":"Neri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ijid.2020.10.021_bib0085","first-page":"e202340","article-title":"Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic [published online ahead of print, 2020 Jun 25]","author":"Roca-Gin\u00e9s","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0090","article-title":"Recent outbreak of chilblain-like lesions is not directly related to SARS-CoV-2 infection [published online ahead of print, 2020 Jun 26]","author":"Rouanet","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0095","article-title":"Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series [published online ahead of print, 2020 Jul 1]","author":"Rizzoli","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0100","article-title":"No antibody response in acral cutaneous manifestations associated with COVID-19? [published online ahead of print, 2020 Jun 2]","author":"Mahieu","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0105","article-title":"Acute acral cutaneous manifestations during the COVID-19 pandemic: a single-centre experience [published online ahead of print, 2020 Jun 26]","author":"Garc\u00eda-Legaz Mart\u00ednez","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0110","first-page":"e13516","article-title":"Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak [published online ahead of print, 2020 May 6]","author":"Garcia-Lara","year":"2020","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.021_bib0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0120","article-title":"Chilblains in children in the time of Covid-19: new evidence with serology assay [published online ahead of print, 2020 Jun 13]","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0125","article-title":"Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on PCR and serology testing [published online ahead of print, 2020 Jul 6]","author":"Le Cleach","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0130","article-title":"COVID-19 and outbreak of chilblains: are they related? [published online ahead of print, 2020 Jun 27]","author":"Lesort","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0135","article-title":"Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic [published online ahead of print, 2020 Aug 18]","author":"Stavert","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.08.021","article-title":"All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions [published online ahead of print, 2020 Aug 8]","author":"Denina","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0145","article-title":"Negative SARS-CoV-2 PCR in patients with chilblain-like lesions [published online ahead of print, 2020 Jun 18]","author":"Hubiche","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ijid.2020.10.021_bib0150","doi-asserted-by":"crossref","first-page":"104512","DOI":"10.1016\/j.jcv.2020.104512","article-title":"Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation [published online ahead of print, 2020 Jun 15]","volume":"129","author":"J\u00e4\u00e4skel\u00e4inen","year":"2020","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ijid.2020.10.021_bib0155","article-title":"A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2? [published online ahead of print, 2020 Jun 6]","volume":"144","author":"Lipsker","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ijid.2020.10.021_bib0160","article-title":"New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus [published online ahead of print, 2020 Jul 3]","author":"Battesti","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ijid.2020.10.021_bib0165","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.jaad.2020.06.052","article-title":"When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection","volume":"83","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.10.021_bib0170","article-title":"Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology [published online ahead of print, 2020 Jun 12]","author":"Rodr\u00edguez-Villa Lario","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.ijid.2020.10.021_bib0175","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2020.10.021_bib0180","article-title":"Type I interferonopathies: cutaneous vasculopathy, chilblains, panniculitis-induced lipodystrophyand others skin manifestations [published online ahead of print, 2020 Jul 2]","author":"Papa","year":"2020","journal-title":"G Ital Dermatol Venereol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220322256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220322256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:53:08Z","timestamp":1761119588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220322256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"alternative-id":["S1201971220322256"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.021","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID toes: where do we stand with the current evidence?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}